BASF drops GM potato projects


potatoes

© Shutterstock

BASF has announced that it is no longer seeking EU marketing approval for its controversial genetically modified (GM) potatoes.

The company already has approval for one type of GM potato. In 2010, the European commission granted approval for Amflora potatoes, which are used for industrial production of starch, a biopolymer of two monomers: amylose and amylopectin. The latter is the important monomer for industrial purposes. Potatoes typically produce starch that is 20% amylose and 80% amylopectin, but – thanks to genetic modification – Amflora potatoes produce only amylopectin.

BASF had been planning more approvals. But it says that continued investment in Fortuna, Amadea, and Modena potatoes cannot be justified because of ‘uncertainty in the regulatory environment and threats of field destructions’.

The 2010 approval of Amflora potatoes was hailed at the time as key breakthrough for agrichemical companies, which historically had struggled to gain public approval for GM products in Europe. But it proved to be something of a one off, and in January 2012 the company decided to halt development and commercialisation of GM crops in Europe and move its biotech R&D operations to the US, citing consumer and political resistance.

Meanwhile, BASF is also dropping its research into nutritionally enhanced corn, resulting in the closure of six field sites across the midwestern US and the loss of 40 jobs. This will coincide with increased focus on modification for higher yields and improved resistance to stress conditions.


Related Content

Court overturns approval to grow GM potato in Europe

19 December 2013 Business

news image

Europe's second highest court rules that European commission did not follow its own rules when giving Amflora the green light

EC approves first GM crop in a decade

5 March 2010 News Archive

news image

European Commission authorises cultivation of genetically modified potato Amflora, the first new GM crop approved in 12 years

Most Read

Yeast turned into morphine and opioid biofactories

24 August 2014 Research

news image

Scientists hope that biotech route could protect the drug supply chain from harvest failures and problems with illicit use

No-frills coats set a trend for designer viruses

26 August 2014 Research

news image

An artificial protein that self-assembles around and protects DNA could be ideal for gene therapy, nanomachines and synthetic...

Most Commented

3D printing cuts fuel cell component costs

4 July 2014 Research

news image

Hardware hackers encouraged to exploit new manufacturing approach in open source schemes

Next Mars rover will make oxygen from CO2

4 August 2014 News and Analysis

news image

Mars 2020 will set Nasa’s space exploration on a self-sufficiency course